Benefits of dexmedetomidine in management of post-ECT agitation Journal Article uri icon
Overview
abstract
  • Electroconvulsive therapy (ECT) is an intervention for patients with a variety of psychiatric conditions. Occasionally, people exhibit dangerous degrees of agitation after this treatment, and some do not respond well to conventional pharmacotherapies. Dexmedetomidine is a central alpha-2 agonist that can induce significantly calmative effects in persons with post-ECT agitation. The indication for it is in calming individuals with acute and/or recurrent posttreatment agitation. Dexmedetomidine is safe and effective when infused just before, or postictally, at ECT sessions.

  • Link to Article
    publication date
  • 2017
  • published in
  • Journal of ECT  Journal
  • Research
    keywords
  • Adverse Effects
  • Drugs and Drug Therapy
  • Mental Disorders
  • Additional Document Info
    volume
  • 33
  • issue
  • 3